123 related articles for article (PubMed ID: 37410588)
1. Characteristics, management, and outcomes of active cancer patients with cardiogenic shock.
Merdji H; Gantzer J; Bonello L; Lamblin N; Roubille F; Levy B; Champion S; Lim P; Schneider F; Cariou A; Khachab H; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Quentin C; Curtiaud A; Kurtz JE; Combaret N; Marchandot B; Lattuca B; Biendel C; Leurent G; Bataille V; Gerbaud E; Puymirat E; Bonnefoy E; Aissaoui N; Delmas C
Eur Heart J Acute Cardiovasc Care; 2023 Oct; 12(10):682-692. PubMed ID: 37410588
[TBL] [Abstract][Full Text] [Related]
2. Mottling as a prognosis marker in cardiogenic shock.
Merdji H; Bataille V; Curtiaud A; Bonello L; Roubille F; Levy B; Lim P; Schneider F; Khachab H; Dib JC; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Marchand S; Gebhard CE; Henry P; Combaret N; Marchandot B; Lattuca B; Biendel C; Leurent G; Gerbaud E; Puymirat E; Bonnefoy E; Meziani F; Delmas C
Ann Intensive Care; 2023 Sep; 13(1):80. PubMed ID: 37672139
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry.
Delmas C; Roubille F; Lamblin N; Bonello L; Leurent G; Levy B; Elbaz M; Danchin N; Champion S; Lim P; Schneider F; Cariou A; Khachab H; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Quentin C; Delabranche X; Aissaoui N; Combaret N; Manzo-Silberman S; Tomasevic D; Marchandot B; Lattuca B; Henry P; Gerbaud E; Bonnefoy E; Puymirat E
ESC Heart Fail; 2022 Feb; 9(1):408-419. PubMed ID: 34973047
[TBL] [Abstract][Full Text] [Related]
4. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality.
Lu X; Wang X; Gao Y; Walline JH; Yu S; Ge Z; Qin M; Zhu H; Li Y
ESC Heart Fail; 2022 Jun; 9(3):1875-1883. PubMed ID: 35289504
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
Cherbi M; Bouisset F; Bonnefoy E; Lamblin N; Gerbaud E; Bonello L; Levy B; Lim P; Joffre J; Beuzelin M; Roland Y; Niquet L; Favory R; Khachab H; Harbaoui B; Vanzetto G; Combaret N; Marchandot B; Lattuca B; Leurent G; Lairez O; Puymirat E; Roubille F; Delmas C
Int J Cardiol; 2024 Jan; 395():131578. PubMed ID: 37956759
[TBL] [Abstract][Full Text] [Related]
7. Cardiogenic shock in adults with congenital heart disease: Insights from the FRENSHOCK registry.
Karsenty C; Touafchia A; Ladouceur M; Roubille F; Bonnefoy E; Bonello L; Leurent G; Levy B; Champion S; Lim P; Schneider F; Cariou A; Khachab H; Bourenne J; Seronde MF; Harbaoui B; Vanzetto G; Quentin C; Delabranche X; Combaret N; Morel O; Lattuca B; Leborgne L; Fillippi E; Gerbaud E; Brusq C; Bongard V; Lamblin N; Puymirat E; Delmas C;
Arch Cardiovasc Dis; 2023; 116(8-9):390-396. PubMed ID: 37598062
[TBL] [Abstract][Full Text] [Related]
8. Trends in the management and outcomes of patients admitted with acute coronary syndrome complicated by cardiogenic shock over the past decade: Real world data from the acute coronary syndrome Israeli survey (ACSIS).
Kalmanovich E; Blatt A; Brener S; Shlezinger M; Shlomo N; Vered Z; Hod H; Goldenberg I; Elbaz-Greener G
Oncotarget; 2017 Jun; 8(26):42876-42886. PubMed ID: 28476027
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
10. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section.
Tavazzi G; Rossello X; Grand J; Gierlotka M; Sionis A; Ahrens I; Hassager C; Price S
Eur Heart J Acute Cardiovasc Care; 2022 Sep; 11(9):706-711. PubMed ID: 35941730
[TBL] [Abstract][Full Text] [Related]
12. Differential Prognostic Implications of Vasoactive Inotropic Score for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock According to Use of Mechanical Circulatory Support.
Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ko YG; Yu CW; Chun WJ; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Cho S; Gwon HC
Crit Care Med; 2021 May; 49(5):770-780. PubMed ID: 33590998
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
14. Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry.
Manzo-Silberman S; Martin AC; Boissier F; Hauw-Berlemont C; Aissaoui N; Lamblin N; Roubille F; Bonnefoy E; Bonello L; Elbaz M; Schurtz G; Morel O; Leurent G; Levy B; Jouve B; Harbaoui B; Vanzetto G; Combaret N; Lattucca B; Champion S; Lim P; Bruel C; Schneider F; Seronde MF; Bataille V; Gerbaud E; Puymirat E; Delmas C;
J Crit Care; 2024 Aug; 82():154785. PubMed ID: 38493531
[TBL] [Abstract][Full Text] [Related]
15. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
[TBL] [Abstract][Full Text] [Related]
16. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
[TBL] [Abstract][Full Text] [Related]
17. [Management of cardiogenic shock: Results from a survey in France and Belgium].
Champion S; Deye N
Ann Cardiol Angeiol (Paris); 2017 Apr; 66(2):59-65. PubMed ID: 27836099
[TBL] [Abstract][Full Text] [Related]
18. Role of medical management of cardiogenic shock in the era of mechanical circulatory support.
Blumer V; Marbach J; Veasey T; Kanwar M
Curr Opin Cardiol; 2022 May; 37(3):250-260. PubMed ID: 35612937
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.
Yang JH; Choi KH; Ko YG; Ahn CM; Yu CW; Chun WJ; Jang WJ; Kim HJ; Kim BS; Bae JW; Lee SY; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Lim SH; Cho S; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Gwon HC
Circ Heart Fail; 2021 Jun; 14(6):e008141. PubMed ID: 34129366
[TBL] [Abstract][Full Text] [Related]
20. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
